Heart failure (HF) is a rapidly growing public health issue with an estimated prevalence of >37.7 million individuals globally. HF is a shared chronic phase of cardiac functional impairment secondary to many aetiologies, and patients with HF experience a range of symptoms that affect their quality of life, including dyspnoea, fatigue, poor exercise tolerance and fluid retention.

The burden of HF will continue to rise, due to population aging, population growth and improved treatment of HF and other cardiovascular disorders. As a result, clinicians will be increasingly challenged to develop treatment plans and care systems that reduce the high levels of morbidity and mortality experienced by these patients, both from their HF and other comorbidities.

Related Articles


A Case of Osseocartilaginous Defects and CV Anomalies

Aritra Paul, Aruni Ghose, Debasish Banerjee,


Citation: Journal of Asian Pacific Society of Cardiology 2022;1:e02.

Transitional Care to Reduce Readmission Rates

Wan Xian Chan, Weiqin Lin, Raymond Ching Chiew Wong,

Citation: Cardiac Failure Review 2016;2(2):85–9

Inherited Channelopathies and Cardiomyopathies - When Is Invasive Risk…

Kit Chan, Hung-Fat Tse,

Citation: Asia-Pacific Cardiology 2011;3(1):64-6

Innovative Cardiac Diagnostics - Key to the Total Management of…

Jenny Charlton,

Citation: Asia-Pacific Cardiology 2011;3(1):19–29